Safe use of landiolol hydrochloride in a patient with marked pseudocholinesterase deficiency

J Anesth. 2010 Apr;24(2):309-10. doi: 10.1007/s00540-010-0889-2. Epub 2010 Feb 13.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use*
  • Aged, 80 and over
  • Anesthesia, General / methods*
  • Butyrylcholinesterase / deficiency*
  • Butyrylcholinesterase / drug effects
  • Humans
  • Male
  • Morpholines / therapeutic use*
  • Treatment Outcome
  • Urea / analogs & derivatives*
  • Urea / therapeutic use
  • Ventriculoperitoneal Shunt

Substances

  • Adrenergic beta-Antagonists
  • Morpholines
  • landiolol
  • Urea
  • Butyrylcholinesterase